This dependency on MCL-1 is further driven by both genetic and functional alterations in tumor cells that will be addressed in the current review and presented alongside upcoming treatment strategies that specifically target MCL-1 dependency in tumor cells. The gene discussed is MCL1; the disease is neoplasm.